Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use NEOPROFEN safely and effectively. See full prescribing information for NEOPROFEN. NEOPROFEN® (ibuprofen lysine) Injection, for intravenous use Initial U.S. Approval: 1974
Medication labelWhy this: Advisory · dailymed-prescription
NeoProfen is indicated to close a clinically significant patent ductus arteriosus (PDA) in premature infants weighing between 500 and 1500 g, who are no more than 32 weeks gestational age when usual medical management (e.g., fluid restriction, diuretics, respiratory support, etc.) is ineffective. The clinical trial was conducted among infants with an asymptomatic PDA. However, the consequences beyond 8 weeks after treatment have not been evaluated; therefore, treatment should be reserved for infants with clear evidence of a clinically significant PDA.
- generic_name
- ibuprofen lysine
- product_names
- ibuprofen lysine
- ndc
- 55292-122, 55292-122-52
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en